Resource Center

New Information

  • The FDA Office of Surveillance & Epidemiology released a report on a retrospective cohort study that was conducted in over 835,000 women to evaluate the thromboembolic risks of  new combined hormonal contraceptive products.  The results found that drospirenone/ethinyl estradiol tablets, norelgestromin/ethinyl estradiol transdermal patch and etonogestrel/estradiol vaginal ring are all associated with increased VTE risk.  Read more
  • The ADOPT trial showed that extended VTE prophylaxis with apixaban in medically ill patients was not superior to a standard duration of enoxaparin in preventing 30 day composite endpoint of VTE related death, PE or DVT.  Apixaban increased the risk of major bleeding compared to enoxaparin. Read more
  • 4- year prospective patient-safety and quality improvement project implementing a VTE-prevention study in the pediatric population was published. Read more
  • In September 2011, the American Academy of Orthopaedic Surgeons released updated guidelines entitled “Preventing Venous Thromboembolic Disease in Patients Undergoing Elective Hip and Knee Arthroplasty.” Read more
  • Rivaroxaban (Xarelto®) was approved by the U.S. Food and Drug Administration on July 1, 2011, to reduce the risk of venous thromboembolism (VTE) after knee or hip replacement surgery. Read more
  • Edoxaban (Lixiana®) was approved in Japan on April 22, 2011, for the prevention of VTE after major orthopedic surgery.  Read more

eNewsletters

January 2011 Issue
Expand Your Knowledge
Of VTE Prevention
Challenges in Implementing Quality Improvement Strategies for VTE Prophylaxis
0.25 hour CPE


 

VTE Prevention Resources

The Surgeon General’s Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism. 2008. Preventing Hospital-Acquired Venous Thromboembolism: A Guide for Effective Quality Improvement. Agency for Healthcare Research and Quality. 2008.
Health Services Advisory Group VTE Guide for Executive Leadership Society of Hospital Medicine Venous Thromboembolism Resource Room

Guidelines/Consensus Statements

Prevention of Venous thromboembolism: American College of Chest Physicians Evidence-based Clinical Practice Guidelines, 8th edition. 2008.
Full Text Guidelines
American Society of Clinical Oncology Guideline: Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients with Cancer. 2007.
Full Text Guidelines
Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition)
Full Text Guidelines

American Academy of Orthopedic Surgeons: Preventing Venous Thromboembolic Disease in Patients Undergoing Elective Hip and Knee Arthroplasty. 2011.
Full Text Guidelines

Delivery of Optimized Anticoagulant Therapy: Consensus Statement from the Anticoagulation Forum 2008
Full Text Article

Institute for Clinical Systems Improvement: Antithrombotic Therapy Supplement. 2011.
Full Text Guidelines

American College of Obstetricians and Gynecologists Practice Bulletin: Prevention of DVT and PE. 2007.
Full Text Guidelines (Subscription Required)

American College of Obstetricians and Gynecology Practice Bulletin: Thromboembolism in Pregnancy – update includes Cesarean Deliveries. 2011.
Full Text Guidelines (Subscription Required)

Standards/ Performance Measures

National Consensus Standards for Prevention and Care of Venous Thromboembolism
Joint project between The Joint Commission and the National Quality Forum (NQF), initiated in 2004, to develop and standardize performance measures for the prevention and care of venous thromboembolism.
Surgical Care Improvement Project
The Surgical Care Improvement Project (SCIP) is a national quality partnership of organizations focused on improving surgical care by significantly reducing surgical complications. SCIP targets four areas, including deep vein thrombosis (DVT). The SCIP measures are included in The Joint Commission Specifications Manual for National Hospital Inpatient Quality Measures.

Useful Web Sites

The Anticoagulation Forum
The Anticoagulation Forum is a multidisciplinary nonprofit organization of health care professionals that will improve the quality of care for patients taking antithrombotic medications.
ASHP Anticoagulation Resource Center
The American Society of Health-System Pharmacists' on-line resource center is a compilation of anticoagulation materials selected to assist practitioners in managing patient anticoagulation.
Clotblog
Samuel Z Goldhaber, MD, Director, Venous Thromboembolism Research Group and Co-Director, Anticoagulation Management Service at Brigham and Women's Hospital maintains a video “ClotBlog”, posting weekly entries on up-to-date topics in antithrombotic therapy.
ClotCare Online Resource
ClotCare strives to help others improve lives by providing both patients and healthcare providers with the most up-to-date information and expert insight on optimal use of antithrombotic and anticoagulant therapy.
Coalition to Prevent Deep-Vein Thrombosis
The Coalition to Prevent Deep-Vein Thrombosis is a group of more than 60 organizations who have joined the Coalition in a united effort to raise awareness of DVT among consumers, healthcare professionals, policy-makers and public health leaders.
European Thrombosis Research Organization
The European Thrombosis Research Organization is an international non-profit organization, that aims to promote education and scientific research on all aspects of thrombosis and haemostasis.
International Society on Thrombosis and Haemostasis
The International Society on Thrombosis and Haemostasis is a worldwide organization dedicated to the advancement of understanding, prevention, diagnosis and treatment of thrombotic and bleeding disorders.
National Blood Clot Alliance
The National Blood Clot Alliance (NBCA) is a patient-led, voluntary health advocacy organization. NBCA programs include patient education and professional training on the signs, symptoms, and prevention of blood clots and clotting disorders.
North American Thrombosis Forum
The North American Thrombosis Forum (NATF) is a multi-disciplinary organization founded with the objective of improving patient care through the advancement of thrombosis education. 
University of Washington Medicine Department of Pharmacy Anticoagulation Services shares their anticoagulation guidelines and protocols.
Venous Disease Coalition
The goal of the Venous Disease Coalition is to disseminate science-based information about venous disease to the public and healthcare professionals with the hope of empowering people to protect themselves and their family members from venous disease.
 

Suggested Reading

VTE Prevention
Dobesh PP et al. Key articles and guidelines for the prevention of venous thromboembolism. Pharmacotherapy. 2009;29:410-58.
Goldhaber SZ et al. Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients. NEJM Nov. 13, 2011. 10.1056/NEJMoa1110899.
Phung OJ et al. Dosing frequency of unfractionated heparin thromboprophylaxis: a meta-analysis. Chest. 2011;140:374-81.
 
VTE Quality Improvement
Butkievich LE et al. Impact of a Student-Supported Pharmacy Assessment Program on Venous Thromboembolism Prophylaxis Rates in Hospitalized Patients. Am J Pharm Educ. 2010; 74(6): 105.
Maynard G et al. Designing and implementing effective venous thromboembolism prevention protocols: lessons from collaborative efforts. J Thromb Thrombolysis. 2010;29:159-66.
Maynard GA et al. Optimizing prevention of hospital-acquired venous thromboembolism (VTE): prospective validation of a VTE risk assessment model. J Hosp Med. 2010;5:10-8.
Raffini et al. Thromboprophylaxis in a Pediatric Hospital: A Patient-Safety and Quality-Improvement Initiative. Pediatrics 2011;127:e1326-e1332.